Studying gut bacteria in people with chronic liver disease
Looks at gut bacteria in people with long-lasting liver disease to learn how it develops.
Key facts
- Who runs it
- Chungnam National University Hospital
- Where
- Daejeon, South KoreaSee the site
- Trial code
- Registry title
- Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome
- Status
- Recruiting
- People taking part
- 3,000 people, planned
- Started
- 8 Jul 2024
- Expected to end
- 8 Jul 2029
- Type of study
- Observational
- Record updated
- 20 March 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis, non-alcoholic fatty liver disease or liver abscess. People who live with such a patient can also join.
- Age
- 19 years and older
- Sex
- Women and men can join.
Main reasons for not taking part
- People under 19 years of age
- Patients or guardians who do not consent to take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Adults aged 19 years and older diagnosed with autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis, non-alcoholic fatty liver disease, or liver abscess, who have consented to participate in this study at Chungnam National University Hospital
- Adults aged 19 years and older, who are cohabitants of patients diagnosed with autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis, non-alcoholic fatty liver disease, or liver abscess, and have consented to participate in this study at Chungnam National University Hospital
- Exclusion
Who cannot take part
- Individuals under the age of 19
- Patients or guardians who do not consent to participate in the study
This trial is currently available in South Korea.
- Chungnam National University HospitaDaejeon, South KoreaContact: HyukSoo EunTaking people
About the trial
What the trial wants to find out
In this study, we aim to identify gut microbiomes specific to patients with chronic refractory liver disease and to conduct a gut-liver axis study on the pathogenesis and disease progression.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Exploration of Liver-gut Axis Through Identification of Liver Disease-specific Microbiome
- Plain-language title
- Studying gut bacteria in people with chronic liver diseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 20 March 2026